InvestorsHub Logo
Followers 0
Posts 160
Boards Moderated 0
Alias Born 06/14/2004

Re: hoss75 post# 9

Tuesday, 01/25/2005 8:34:00 PM

Tuesday, January 25, 2005 8:34:00 PM

Post# of 172
I have been communicating with Doug Broadfoot,
Director, Clinical Sales and Marketing
E-mail dbroadfoot@responsebio.com

His response is that the U.S is their main focus, not Canada.
Can you believe that? We should all bombard him with emails protesting their line of thinking!

Come on people, demand an explanation!
--------------------------

Consumers

For questions about any of our products contact:

Monday to Friday 8:00 a.m. to 5:00 p.m. PST
Toll free in North America 1.888.591.5577
or 604.681.4101 Fax: 604.412.9830

Joanne Stephenson
Vice President of Business Development
E-mail jstephenson@responsebio.com


Sales and Marketing
Biodefense and Environmental Infectious Diseases
E-mail Sales

Doug Broadfoot
Director, Clinical Sales and Marketing
E-mail dbroadfoot@responsebio.com

Investors

Investors are encouraged to review the Company’s website where all publicly available information reported by the Company is available. For clarification, please contact:

Don Bradley
Director, Corporate Communications
Tel. 604.681.4101
E-mail dbradley@responsebio.com

To Order:

Mailing Address:

Response Biomedical Corp.
8081 Lougheed Highway,
Burnaby, B.C. V5A 1W9, Canada


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.